Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease
AUTOR(ES)
Mattes, Joerg
FONTE
National Academy of Sciences
RESUMO
Allergic asthma is an inflammatory disease of the lung characterized by abnormal T helper-2 (TH2) lymphocyte responses to inhaled antigens. The molecular mechanisms leading to the generation of TH2 responses remain unclear, although toll-like receptors (TLRs) present on innate immune cells play a pivotal role in sensing molecular patterns and in programming adaptive T cell responses. Here we show that in vivo activation of TLR4 by house dust mite antigens leads to the induction of allergic disease, a process that is associated with expression of a unique subset of small, noncoding microRNAs. Selective blockade of microRNA (miR)-126 suppressed the asthmatic phenotype, resulting in diminished TH2 responses, inflammation, airways hyperresponsiveness, eosinophil recruitment, and mucus hypersecretion. miR-126 blockade resulted in augmented expression of POU domain class 2 associating factor 1, which activates the transcription factor PU.1 that alters TH2 cell function via negative regulation of GATA3 expression. In summary, this study presents a functional connection between miRNA expression and asthma pathogenesis, and our data suggest that targeting miRNA in the airways may lead to anti-inflammatory treatments for allergic asthma.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2773983Documentos Relacionados
- Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer
- MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer
- T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function
- MicroRNA control of PHABULOSA in leaf development: importance of pairing to the microRNA 5′ region
- Th2 cytokines and asthma — The role of interleukin-5 in allergic eosinophilic disease